Now trading at a price of $19.2, Healthpeak Properties has moved -2.3% so far today.
Over the last year, Healthpeak Properties logged a -2.5% change, with its stock price reaching a high of $22.38 and a low of $15.24. Over the same period, the stock underperformed the S&P 500 index by -26.9%. AThe company's 50-day average price was $19.16. Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Based in Denver, CO, the Large-Cap Real Estate company has 193 full time employees. Healthpeak Properties has offered a 6.1% dividend yield over the last 12 months.
Generally Positive Cash Flows but a Highly Leveraged Balance Sheet:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (k) | $422,551 | $415,281 | $437,505 | $457,699 | $526,635 | $543,463 |
| Operating Margins | 11% | 11% | 15% | 14% | 10% | 8% |
| Net Margins | 14% | 19% | 16% | 19% | 21% | 8% |
| Net Income (k) | $58,321 | $77,186 | $68,488 | $86,783 | $110,036 | $43,767 |
| Net Interest Expense (k) | $66,183 | $65,022 | $57,179 | $60,136 | $72,234 | $81,351 |
| Depreciation & Amort. (k) | $158,389 | $146,436 | $149,590 | $157,870 | $189,641 | $191,091 |
| Diluted Shares (k) | 187,847 | 194,961 | 211,146 | 223,061 | 239,610 | 249,345 |
| Earnings Per Share | $0.3 | $0.39 | $0.32 | $0.39 | $0.46 | $0.17 |
| EPS Growth | n/a | 30.0% | -17.95% | 21.88% | 17.95% | -63.04% |
| Avg. Price | $12.07 | $14.26 | $14.8 | $16.25 | $16.21 | $19.16 |
| P/E Ratio | 40.23 | 36.56 | 46.25 | 41.67 | 35.24 | 106.44 |
| Free Cash Flow (k) | $174,056 | $161,040 | $199,231 | $214,208 | $218,531 | $273,430 |
| CAPEX (k) | $34,638 | $40,137 | $33,887 | $32,566 | $39,869 | n/a |
| EV / EBITDA | 18.09 | 22.01 | 20.39 | 23.98 | 22.45 | 27.27 |
| Total Debt (k) | $1,532,853 | $1,634,453 | $1,438,850 | $1,911,918 | $1,818,117 | $1,973,037 |
| Net Debt / EBITDA | 7.39 | 8.49 | 6.73 | 8.57 | 7.45 | 7.77 |
Healthpeak Properties has weak operating margins with a negative growth trend, declining EPS growth, and a highly leveraged balance sheet. On the other hand, the company has generally positive cash flows working in its favor.
a Lower P/B Ratio Than Its Sector Average but Trading Above Its Fair Price:
Healthpeak Properties has a trailing twelve month P/E ratio of 54.7, compared to an average of 27.5 for the Real Estate sector. Based on its EPS guidance of $0.47, the company has a forward P/E ratio of 40.8. The 6.6% compound average growth rate of Healthpeak Properties's historical and projected earnings per share yields a PEG ratio of 8.26. This suggests that these shares are overvalued. In contrast, the market is likely undervaluing Healthpeak Properties in terms of its equity because its P/B ratio is 1.52 while the sector average is 2.1. The company's shares are currently trading 194.9% below their Graham number.
Healthpeak Properties Has an Average Rating of Buy:
The 14 analysts following Healthpeak Properties have set target prices ranging from $19.0 to $25.0 per share, for an average of $22.07 with a buy rating. The company is trading -13.0% away from its average target price, indicating that there is an analyst consensus of some upside potential.
Healthpeak Properties has an average amount of shares sold short because 2.3% of the company's shares are sold short. Institutions own 93.1% of the company's shares, and the insider ownership rate stands at 0.31%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 16% stake in the company is worth $2,200,934,214.
